Objective: The aim of this study was to compare serum anti-phenolic glycolipid-1 IgA, IgG, and IgM levels in leprosy patients and controls.
| INTRODUCTION
Leprosy is a chronic infectious disease which is transmitted through droplets from an index case presenting the multibacillary form of the disease to persons living in the same house or nearby 1 ; nonetheless, it cannot be ruled out that skin lesions rich in viable bacilli might be potential sources of transmission. 2 Brazil comprises the group of 14 countries responsible for 95% of new cases of leprosy in the world. 3 The overall detection rate of cases in Brazil was 14.06 cases per 100 000 inhabitants in 2015. 4 The North and Midwest regions presented the highest incidence of leprosy, that is, 29.59 and 36.69 new cases per 100 000 inhabitants, respectively, in that same year. 4 The Northeastern Region showed an overall detection rate of 22.71 cases per 100 000 inhabitants. 4 In Alagoas (which is situated in the Northeastern Region), the Secretariat of Health reported that Rio
Largo and Santana do Ipanema presented an overall detection rate of 19 .82 and 39.79 cases per 100 000 inhabitants, respectively, in 2015. 4 Another important parameter in the epidemiology of leprosy concerns to the case detection rate among children under 15 years of age, once it is probably related to recent infection and active focus of transmission in the community. 5 The Northern, Midwestern, and
Northeastern regions also presented the highest frequencies of leprosy cases among children under 15 years of age, that is, 9.62, 7.89, and 7.46 cases per 100 000 individuals. 4 The diagnosis of leprosy is essentially based on clinical and epidemiological studies. Considering the mode of transmission, contacts from non-treated multibacillary leprosy patients, are more prone to develop the disease than the general population. 6, 7 One of the major challenges in leprosy is the disease diagnosis which is based mostly on the professional skills in searching for skin lesions and peripheral nerve alteration. Skin smears are neither often positive nor the serology. Although serology is not used in routine, it has been widely explored in research studies since the discovery of the phenolic glycolipid antigen 1 (PGL 1), a molecule specific of Mycobacterium leprae. 8, 9 Enzyme-linked immunosorbent assays (ELISA) for the detection of anti-PGL 1 IgM antibodies in serum have shown high diagnostic sensitivity mostly for the multibacillary form of the disease. 10, 11 Based on the fact that phenolic glycolipid antigen is a T-independent antigen, the IgM isotype against PGL-1 is the only isotype most frequently searched in serum samples from patients and contacts. 12, 13 Although the test for anti-PGL1 serum IgG presents a high diagnostic specificity, 14 it lacks diagnostic sensitivity. 15 Very few reports were found concerning serum anti-PGL1 IgA isotype.
16,17
According to these authors, the subclass antibody anti-PGL1 IgA1 was correlated with the bacterial index in leprosy.
The importance of IgA for mucosal host immunity is well established [18] [19] [20] ; however, knowledge about its protective role in systemic circulation is still doubtful. 21 Nonetheless, in the last few years there has been increasing evidence of its usefulness for diagnosis of infectious diseases, such as leptospirosis, 22 toxoplasmosis, 23 and dengue. [24] [25] [26] The IgA isotype presents an advantage in comparison to the IgM and IgG isotypes because it appears early in infection and disappears much faster than them. 26 Thus, the purpose of the present work was to compare serum anti-PGL1 IgA, IgG and IgM levels in leprosy patients and controls.
| MATERIALS AND METHODS

| Controls and leprosy patients
The leprosy patients (n=54) were divided according to the WHO operational classification, 27 that is, up to five skin lesions (paucibacillary form) and more than five skin lesions (multibacillary form The patients were selected according to the registration at the National Notifiable Diseases System (SINAN) by the Municipal Health
Secretariat. The patients were invited to go to the municipal health centers where the project was explained, and, after informed consent, a questionnaire was applied.
Seventeen individuals (who reported no contact with leprosy patients) living in São Paulo city which presents a low incidence of leprosy (1.47 cases per 100 000 inhabitants), 4 were also included in the project for serological evaluation (control group -CT group).
The study was approved by the Ethics Committee of Universidade
Federal do Ceará, and each participant or his/her guardian was asked to sign a written informed consent.
| Samples
Five milliliters of venous blood were collected into clot activator tubes containing gel separator. After 30 minutes, the samples were centrifuged at 1500× g for 10 minutes, and the serum was separated and stored at −20°C.
| Serum antibody titers
Serological analyses for anti-PGL1 antibodies were performed according to the procedure described elsewhere, 28 with some modifications. The results were expressed in indices according to the following formula: optical density (OD) mean of the test sample (minus blank) divided by the OD mean of the normal human serum pool (minus blank). 28 Blood donors were seronegative donors to HIV, Chagas, hepatitis B and C, HTLV, syphilis and that did not have leprosy at the time of sample collection.
| Statistical analysis
The data were analyzed using non-parametric tests once the data did 
| Correlation between serum anti-PGL1 antibody titers
A weak correlation was found between serum IgG and IgA isotypes among the MB patients (Spearman correlation, r=.363; P=.04, Figure 2A ); a moderate correlation was found between serum IgM F I G U R E 1 Titers of serum anti-PGL1 IgM, IgG, and IgA in nonendemic controls (CT, n=17), and in paucibacillary (PB, n=22) and multibacillary (MB, n=32) leprosy patients F I G U R E 2 Correlation between serum anti-PGL1 IgG, IgA, and IgM in multibacillary leprosy patients and IgG isotypes (r=.479, P=.0055, Figure 2B) , and a strong correlation was found between serum IgM and IgA isotypes (r=.745, P<.0001, Figure 2C ). In respect to the PB patients (n=22), a moderate correlation was found in all analyses, that is, between serum IgG and IgA isotypes (r=.509; P=.015, Figure 3A ), between serum IgM and IgG isotypes (r=.645, P=.0012, Figure 3B ), and between serum IgM and IgA isotypes (r=.595, P=.0035, Figure 3C ).
| Receiver operating characteristic (ROC) curves, diagnostic sensitivities and specificities, negative and positive predictive values
Data from patients and controls were used to build the ROC curves, as represented in Figures 4A-C 
| Assessment of the degree of agreement between serum anti-PGL1 IgM and anti-PGL1
IgA tests
Serum samples from the leprosy patients (n=54) were tested for agreement between anti-PGL1 IgA and IgM tests. The Table 2 shows the frequency of positive and negative titers for both isotypes. The index Kappa was 0.48, calculated according to described elsewhere, 30 and presented a moderate agreement.
| DISCUSSION
The high number of new cases of leprosy reported every year in Brazil reveals that the control of the disease is far from being achieved.
F I G U R E 3
Correlation between serum anti-PGL1 IgG, IgA and IgM in paucibacillary leprosy patients The question that has arisen at that time was in respect to the real meaning of seropositivity of anti-PGL 1 IgM antibodies. False-positive results are described in the literature in various circumstances. For example, rheumatoid factors may be produced in low amounts in infectious diseases, such as toxoplasmosis, 33 malaria, 34 dengue, 35 which lead to non-specific IgM detection. Some authors have described the existence of cross-reacting idiotypes, that is, specific antibodies that use the same antigenic site to interact with an unrelated epitope.
36
In respect to the PGL-1 antigen, as a glycophenolic molecule, it is at risk of being affected when a long period of incubation is performed. For this reason, the adsorption incubation step was reduced to 2 hours at 37 o C.
Another observation was related to the blocking step. Some The cut-off value for each isotype was selected based on the ROC curves. Unfortunately, it was not possible to obtain very high diagnostic sensitivities. 37 We speculate that for leprosy surveys, it is more important that the test presents a good specificity in spite of its sensitivity. Our suggestion is based on the fact that leprosy contacts with abnormal levels of anti-PGL1 shall be surveyed. For this reason, it is rather necessary that the biomarker bear a good specificity in order that it will provide a good positive predictive value. On the other hand, to compensate for the low negative predictive value it is useful to use two or more serological parameters.
As it has been shown in previous studies, lipid antigen may elicit T-dependent humoral immune responses in case the bacteria are ingested by phagocytes. 38 As the presence of anti-PGL1 IgG has been demonstrated in leprosy patients 28 and in contacts, 14 we have decided in the present work to evaluate anti-PGL1 IgA titers.
IgA is being considered as an alternative or complementary biomarker in the diagnosis of some pathologies. For instance, it is considered to be more sensitive than the IgM test for the diagnosis of congenital toxoplasmosis. 39 IgA is also considered to be a good candidate for the diagnosis of acute dengue by the fact it remains shorter time in circulation than IgM does. 26 Finally, in the decade of 1990, it has been suggested that IgA could be used in early stages of the leprosy disease and in subclinical infection. 16, 17 Our current data demonstrated a better performance of the IgA than the IgG isotype. IgG presented a moderate correlation with IgM T A B L E 1 Diagnostic sensitivity and specificity, negative and positive predictive values of anti-PGL1 IgA, IgM, and IgG tests in leprosy patients with the multibacillary (n=32) and paucibacillary (n=22) forms and in non-endemic controls (n=17 
